Literature DB >> 34074651

Factors Associated With Healing of Diabetes-Related Foot Ulcers: Observations From a Large Prospective Real-World Cohort.

Yuqi Zhang1,2,3, Susanna Cramb4,2,3, Steven M McPhail4,2,5, Rosana Pacella6, Jaap J van Netten4,7, Qinglu Cheng8, Patrick H Derhy9, Ewan M Kinnear10, Peter A Lazzarini.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34074651      PMCID: PMC8578884          DOI: 10.2337/dc20-3120

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


× No keyword cloud information.
Diabetes-related foot ulcers (DFUs) affect around 20 million people annually and are a leading cause of the global disability burden (1). DFUs are complex to treat, take months to heal, result in poorer quality of life, and place patients at high risk of hospitalization and amputation. Thus, understanding the influence that different factors have on healing of DFUs is vital. Various demographic, comorbidity, limb, ulcer, and treatment-related factors associated with healing of DFUs have been identified from cohorts attending mostly metropolitan tertiary centers (2–4). However, very few studies have prospectively investigated the influence that these and other factors have on healing in more real-world DFU cohorts attending geographically diverse secondary and tertiary centers. Therefore, we aimed to investigate the influence of 34 factors on healing in a large real-world DFU cohort. We prospectively examined 4,832 consecutive patients with DFU(s) that presented for their first visit to 1 of 65 secondary or tertiary diabetic foot services, across 15 of 17 regions in Queensland (Australia), between July 2011 and December 2017. A DFU was defined as a full-thickness wound below the ankle on a person with diabetes. For DFU clinical and research purposes, foot-related health professionals using the Queensland High Risk Foot Form (QHRFF) directly examined each patient clinically at their first (and subsequent) visit for 4 demographic, 9 comorbidity, 6 limb, 3 ulcer, and 12 treatment factors (5). For those with multiple DFUs, we used the most severe score for each factor and the combined ulcer size from all DFUs (5). Factors from the first visit were used as the baseline. Subsequent visit examinations determined if the DFU(s) healed, defined as complete epithelialization of all DFUs without amputation, death, or recurrence within 1 month. The QHRFF is valid and reliable for the direct capture of these factors by the foot-related health professionals that were trained with a QHRFF manual (5). DFUs healed within 3 and 12 months were the primary outcomes, as different factors have been reported to influence short- and longer-term healing (2–4). All factors were analyzed at a univariable level, with those achieving P < 0.1 entered into multivariable logistic regression models to examine factors independently associated with each outcome. Before analysis, we excluded 123 patients lost to follow-up after baseline visit, excluded factors with >25% missing data, and used multiple imputation for factors with <25% missing data. All analyses were performed using Stata/SE version 16.1 (StataCorp, TX, USA). Of 4,709 included patients (median age 63 years [interquartile range 54–72], 69.5% male, 91.0% with type 2 diabetes, 10.5% Indigenous Australians), 1,956 (41.5%) healed within 3 months and 3,012 (64.0%) within 12 months. After entering 18 factors into the multivariable models (Fig. 1), 7 were negatively associated with DFU healing within both 3 and 12 months, including younger age (<50 years), geographical remoteness, smoking, peripheral arterial disease, large ulcer sizes, deep ulcers, and infection, while receiving knee-high offloading treatment at baseline was positively associated with healing (all P ≤ 0.05). Other factors negatively associated with healing within 3 months were neuropathy, and those for healing within 12 months were previous amputation and recent surgical and medical specialist treatment (at baseline or the prior week).
Figure 1

Multivariable analysis of factors associated with healing of DFUs within 3 months and 12 months. All included variables are those with P < 0.10 on the univariable analysis. Statistically significant (P < 0.05) factors associated with lower likelihood to heal are highlighted in red, statistically significant factors associated with higher likelihood to heal are in green, and variables not found to be significant (P > 0.05) are in gray. Multiple imputation was used to impute variables with <25% missing data, including geographical remoteness, previous amputation, neuropathy, peripheral arterial disease, ulcer size, infection, deep ulcer, debrided ulcer, and knee-high offloading. The multivariable logistic model for healing at 3 months was built including patients with at least a 3-month follow-up (n = 4,323). The multivariable logistic model for healing at 12 months was built including patients with at least a 12-month follow-up (n = 3,999). OR, odds ratios. ^The results of the category “Yes” are presented, with the category “No” used as the reference group for this variable.

Multivariable analysis of factors associated with healing of DFUs within 3 months and 12 months. All included variables are those with P < 0.10 on the univariable analysis. Statistically significant (P < 0.05) factors associated with lower likelihood to heal are highlighted in red, statistically significant factors associated with higher likelihood to heal are in green, and variables not found to be significant (P > 0.05) are in gray. Multiple imputation was used to impute variables with <25% missing data, including geographical remoteness, previous amputation, neuropathy, peripheral arterial disease, ulcer size, infection, deep ulcer, debrided ulcer, and knee-high offloading. The multivariable logistic model for healing at 3 months was built including patients with at least a 3-month follow-up (n = 4,323). The multivariable logistic model for healing at 12 months was built including patients with at least a 12-month follow-up (n = 3,999). OR, odds ratios. ^The results of the category “Yes” are presented, with the category “No” used as the reference group for this variable. This prospective study of a large, diverse, real-world DFU cohort (equivalent to ∼50% of ∼9,000 people with DFU each year in Queensland [1]) first confirms previously reported limb and ulcer-related factors that negatively influence healing of DFU in cohorts attending mostly metropolitan tertiary centers, including neuropathy, peripheral arterial disease, previous amputation, larger ulcer size, deep ulcers, and infection (2–4). Second, it confirms the previously reported harmful effect of smoking on DFU healing from smaller tertiary center cohorts. Third, and perhaps most importantly, we seemed to identify new factors positively (current knee-high offloading treatment) and negatively (younger age, geographical remoteness, and recent specialist treatment) influencing healing of DFU. Concerning these new findings, we suggest the negative influence of younger age to potentially be a surrogate for younger-onset type 2 diabetes, emerging as a more severe phenotype for (foot) complications. Geographical remoteness and recent specialist treatment are likely surrogates for delayed access and/or more severe presentation to specialist diabetic foot services, reinforcing the impact of early access to these services on DFU healing. Knee-high offloading treatment confirms trial findings and might be a surrogate for the positive influence of guideline-recommended treatment on DFU healing. Interestingly, we did not find Indigenous status, after controlling for geographical remoteness, to be associated with DFU healing. Overall, these new findings confirm and extend our understanding of the influence that severity of DFU presentation, early access to diabetic foot services, and enacting guideline-recommended treatment have on healing DFUs.
  4 in total

1.  Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016.

Authors:  Yuqi Zhang; Peter A Lazzarini; Steven M McPhail; Jaap J van Netten; David G Armstrong; Rosana E Pacella
Journal:  Diabetes Care       Date:  2020-03-05       Impact factor: 19.112

2.  Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing.

Authors:  David J Margolis; Lynne Allen-Taylor; Ole Hoffstad; Jesse A Berlin
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

3.  Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers.

Authors:  Limin Jia; Christina N Parker; Tony J Parker; Ewan M Kinnear; Patrick H Derhy; Ann M Alvarado; Flavia Huygens; Peter A Lazzarini
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

4.  Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study.

Authors:  L Prompers; N Schaper; J Apelqvist; M Edmonds; E Jude; D Mauricio; L Uccioli; V Urbancic; K Bakker; P Holstein; A Jirkovska; A Piaggesi; G Ragnarson-Tennvall; H Reike; M Spraul; K Van Acker; J Van Baal; F Van Merode; I Ferreira; M Huijberts
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

  4 in total
  2 in total

1.  Establishing the national top 10 priority research questions to improve diabetes-related foot health and disease: a Delphi study of Australian stakeholders.

Authors:  Byron M Perrin; Anita Raspovic; Cylie M Williams; Stephen M Twigg; Jonathan Golledge; Emma J Hamilton; Anna Crawford; Carol Hargreaves; Jaap J van Netten; Nytasha Purcell; Peter A Lazzarini
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11

2.  Australian guideline on offloading treatment for foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Malindu E Fernando; Mark Horsley; Sara Jones; Brian Martin; Vanessa L Nube; James Charles; Jane Cheney; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2022-05-05       Impact factor: 3.050

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.